Private Capital Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Private Capital Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,954	Closed	-$528K	–	88
2019 Q3	$528K	Hold	7,954	–	–	0.15%	62
2019 Q2	$633K	Buy	7,954 +354	+5%	+$31.7K	0.18%	62
2019 Q1	$850K	Buy	+7,600	New	+$830K	0.26%	51
2015 Q4	–	Sell	-4,400	Closed	-$730K	–	111
2015 Q3	$730K	Buy	4,400 +2,000	+83%	+$440K	0.31%	71
2015 Q2	$579K	Sell	2,400 -4,750	-66%	-$1.26M	0.19%	97
2015 Q1	$2.02M	Buy	+7,150	New	+$1.55M	0.73%	48
2014 Q4	–	Sell	-4,300	Closed	-$1.02M	–	114
2014 Q3	$1.02M	Buy	+4,300	New	+$1.1M	0.33%	78

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Capital Advisors's ICPT Position: Q4 2019 in Review

Private Capital Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2019, closing a stake of 7,954 shares — an estimated $528K sold.

Private Capital Advisors first reported a position in ICPT in Q3 2014 and held it in 7 quarters. The position peaked at $2.02M in Q1 2015. 215 funds tracked by Wall St. Rank hold ICPT as of Q4 2019.

Private Capital Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Private Capital Advisors sold 7,954 Intercept Pharmaceuticals, Inc. shares in Q4 2019, an estimated $528K.
Private Capital Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2014 and held it in 7 quarters.
Private Capital Advisors's Intercept Pharmaceuticals, Inc. position peaked at $2.02M in Q1 2015.
215 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2019.

Based on Private Capital Advisors's 13F filing for Q4 2019, filed 9 Jan 2020.